HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis

Keenan Walker, Gregory G. Brown

Research output: Contribution to journalArticle

Abstract

Objective: While some reports suggest that HIV+ individuals continue to display executive function (EF) impairment in the era of cART, findings have been contradictory and appear to differ based on the aspect of EF being measured. To improve the understanding of how discrete executive abilities may be differentially affected or spared in the context of HIV infection, we conducted a systematic review and meta-analysis to (a) determine whether and to what extent HIV+ adults experience deficits in EFs, and (b) understand how demographic and clinical characteristics may modify the associations between HIV infection and executive abilities. Method: Studies comparing HIV+ and HIV-uninfected groups on measures of working memory, set-shifting, inhibition, decision-making, and apathy between 2000 and 2017 were identified from three databases. Effect sizes (Cohen’s d) were calculated using inverse variance weighted random effects models. Meta-regression was used to examine the moderating effect of demographic and clinical variables. Results: Thirty-seven studies (n = 3935 HIV+; n = 2483 HIV-uninfected) were included in the meta-analysis. Pooled effect sizes for deficits associated with HIV infection were small for domains of set-shifting (d = −0.34, 95% CI [−0.47, −0.20]) and inhibition (d = −0.31, 95% CI [−0.40, −0.21]), somewhat larger for measures of decision-making (d = −0.41, 95% CI [−0.53, −0.28]) and working memory (d = −0.42, 95% CI [−0.59, −0.29]), and largest for apathy (d = −0.87, 95% CI [−1.09, −0.66]). Meta-regression demonstrated that age, sex, education, current CD4 count, and substance dependence differentially moderated the effects of HIV infection on specific EFs. However, lower nadir CD4 count was the only variable associated with greater deficits in nearly all EF domains. Conclusions: Our results suggest that discrete domains of EF may be differentially affected by HIV infection and moderating demographic and clinical variables. These findings have implications for the development of targeted cognitive remediation strategies.

Original languageEnglish (US)
Pages (from-to)357-376
Number of pages20
JournalJournal of Clinical and Experimental Neuropsychology
Volume40
Issue number4
DOIs
StatePublished - Apr 21 2018

Fingerprint

Meta-Analysis
HIV Infections
Executive Function
HIV
Apathy
Aptitude
Demography
CD4 Lymphocyte Count
Short-Term Memory
Decision Making
Therapeutics
Sex Education
Substance-Related Disorders
Databases
Inhibition (Psychology)

Keywords

  • executive functioning
  • frontal lobe
  • HIV-associated neurocognitive disorder
  • HIV/AIDS
  • neuropsychological functioning

ASJC Scopus subject areas

  • Clinical Psychology
  • Neurology
  • Clinical Neurology

Cite this

@article{81bbcc49aca8468086ad23b3fa215b0b,
title = "HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis",
abstract = "Objective: While some reports suggest that HIV+ individuals continue to display executive function (EF) impairment in the era of cART, findings have been contradictory and appear to differ based on the aspect of EF being measured. To improve the understanding of how discrete executive abilities may be differentially affected or spared in the context of HIV infection, we conducted a systematic review and meta-analysis to (a) determine whether and to what extent HIV+ adults experience deficits in EFs, and (b) understand how demographic and clinical characteristics may modify the associations between HIV infection and executive abilities. Method: Studies comparing HIV+ and HIV-uninfected groups on measures of working memory, set-shifting, inhibition, decision-making, and apathy between 2000 and 2017 were identified from three databases. Effect sizes (Cohen’s d) were calculated using inverse variance weighted random effects models. Meta-regression was used to examine the moderating effect of demographic and clinical variables. Results: Thirty-seven studies (n = 3935 HIV+; n = 2483 HIV-uninfected) were included in the meta-analysis. Pooled effect sizes for deficits associated with HIV infection were small for domains of set-shifting (d = −0.34, 95{\%} CI [−0.47, −0.20]) and inhibition (d = −0.31, 95{\%} CI [−0.40, −0.21]), somewhat larger for measures of decision-making (d = −0.41, 95{\%} CI [−0.53, −0.28]) and working memory (d = −0.42, 95{\%} CI [−0.59, −0.29]), and largest for apathy (d = −0.87, 95{\%} CI [−1.09, −0.66]). Meta-regression demonstrated that age, sex, education, current CD4 count, and substance dependence differentially moderated the effects of HIV infection on specific EFs. However, lower nadir CD4 count was the only variable associated with greater deficits in nearly all EF domains. Conclusions: Our results suggest that discrete domains of EF may be differentially affected by HIV infection and moderating demographic and clinical variables. These findings have implications for the development of targeted cognitive remediation strategies.",
keywords = "executive functioning, frontal lobe, HIV-associated neurocognitive disorder, HIV/AIDS, neuropsychological functioning",
author = "Keenan Walker and Brown, {Gregory G.}",
year = "2018",
month = "4",
day = "21",
doi = "10.1080/13803395.2017.1349879",
language = "English (US)",
volume = "40",
pages = "357--376",
journal = "Journal of Clinical and Experimental Neuropsychology",
issn = "1380-3395",
publisher = "Psychology Press Ltd",
number = "4",

}

TY - JOUR

T1 - HIV-associated executive dysfunction in the era of modern antiretroviral therapy

T2 - A systematic review and meta-analysis

AU - Walker, Keenan

AU - Brown, Gregory G.

PY - 2018/4/21

Y1 - 2018/4/21

N2 - Objective: While some reports suggest that HIV+ individuals continue to display executive function (EF) impairment in the era of cART, findings have been contradictory and appear to differ based on the aspect of EF being measured. To improve the understanding of how discrete executive abilities may be differentially affected or spared in the context of HIV infection, we conducted a systematic review and meta-analysis to (a) determine whether and to what extent HIV+ adults experience deficits in EFs, and (b) understand how demographic and clinical characteristics may modify the associations between HIV infection and executive abilities. Method: Studies comparing HIV+ and HIV-uninfected groups on measures of working memory, set-shifting, inhibition, decision-making, and apathy between 2000 and 2017 were identified from three databases. Effect sizes (Cohen’s d) were calculated using inverse variance weighted random effects models. Meta-regression was used to examine the moderating effect of demographic and clinical variables. Results: Thirty-seven studies (n = 3935 HIV+; n = 2483 HIV-uninfected) were included in the meta-analysis. Pooled effect sizes for deficits associated with HIV infection were small for domains of set-shifting (d = −0.34, 95% CI [−0.47, −0.20]) and inhibition (d = −0.31, 95% CI [−0.40, −0.21]), somewhat larger for measures of decision-making (d = −0.41, 95% CI [−0.53, −0.28]) and working memory (d = −0.42, 95% CI [−0.59, −0.29]), and largest for apathy (d = −0.87, 95% CI [−1.09, −0.66]). Meta-regression demonstrated that age, sex, education, current CD4 count, and substance dependence differentially moderated the effects of HIV infection on specific EFs. However, lower nadir CD4 count was the only variable associated with greater deficits in nearly all EF domains. Conclusions: Our results suggest that discrete domains of EF may be differentially affected by HIV infection and moderating demographic and clinical variables. These findings have implications for the development of targeted cognitive remediation strategies.

AB - Objective: While some reports suggest that HIV+ individuals continue to display executive function (EF) impairment in the era of cART, findings have been contradictory and appear to differ based on the aspect of EF being measured. To improve the understanding of how discrete executive abilities may be differentially affected or spared in the context of HIV infection, we conducted a systematic review and meta-analysis to (a) determine whether and to what extent HIV+ adults experience deficits in EFs, and (b) understand how demographic and clinical characteristics may modify the associations between HIV infection and executive abilities. Method: Studies comparing HIV+ and HIV-uninfected groups on measures of working memory, set-shifting, inhibition, decision-making, and apathy between 2000 and 2017 were identified from three databases. Effect sizes (Cohen’s d) were calculated using inverse variance weighted random effects models. Meta-regression was used to examine the moderating effect of demographic and clinical variables. Results: Thirty-seven studies (n = 3935 HIV+; n = 2483 HIV-uninfected) were included in the meta-analysis. Pooled effect sizes for deficits associated with HIV infection were small for domains of set-shifting (d = −0.34, 95% CI [−0.47, −0.20]) and inhibition (d = −0.31, 95% CI [−0.40, −0.21]), somewhat larger for measures of decision-making (d = −0.41, 95% CI [−0.53, −0.28]) and working memory (d = −0.42, 95% CI [−0.59, −0.29]), and largest for apathy (d = −0.87, 95% CI [−1.09, −0.66]). Meta-regression demonstrated that age, sex, education, current CD4 count, and substance dependence differentially moderated the effects of HIV infection on specific EFs. However, lower nadir CD4 count was the only variable associated with greater deficits in nearly all EF domains. Conclusions: Our results suggest that discrete domains of EF may be differentially affected by HIV infection and moderating demographic and clinical variables. These findings have implications for the development of targeted cognitive remediation strategies.

KW - executive functioning

KW - frontal lobe

KW - HIV-associated neurocognitive disorder

KW - HIV/AIDS

KW - neuropsychological functioning

UR - http://www.scopus.com/inward/record.url?scp=85022202576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022202576&partnerID=8YFLogxK

U2 - 10.1080/13803395.2017.1349879

DO - 10.1080/13803395.2017.1349879

M3 - Article

C2 - 28689493

AN - SCOPUS:85022202576

VL - 40

SP - 357

EP - 376

JO - Journal of Clinical and Experimental Neuropsychology

JF - Journal of Clinical and Experimental Neuropsychology

SN - 1380-3395

IS - 4

ER -